Kingsview Wealth Management, LLC Astrazeneca PLC Transaction History

Kingsview Wealth Management, LLC

$4.45 Billion
Q3 2024

A detailed history of Kingsview Wealth Management, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Kingsview Wealth Management, LLC holds 12,954 shares of AZN stock, worth $859,627. This represents 0.02% of its overall portfolio holdings.

Number of Shares

12,954

Previous 14,212 8.85%

Holding current value

$859,627

Previous $1.11 Million 8.94%

% of portfolio

0.02%

Previous 0.03%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$76.67 - $87.62 $96,450 - $110,225	-1,258 Reduced 8.85%	12,954 $1.01 Million
Q2 2024 Aug 14, 2024	BUY	$66.81 - $80.83 $2,605 - $3,152	39 Added 0.28%	14,212 $1.11 Million
Q1 2024 May 09, 2024	BUY	$61.03 - $69.57 $437,157 - $498,329	7,163 Added 102.18%	14,173 $960,000
Q4 2023 Feb 08, 2024	BUY	$61.89 - $69.28 $44,003 - $49,258	711 Added 11.29%	7,010 $472,000
Q3 2023 Nov 07, 2023	BUY	$64.85 - $71.7 $74,707 - $82,598	1,152 Added 22.38%	6,299 $426,000
Q2 2023 Aug 10, 2023	SELL	$69.91 - $75.81 $7,620 - $8,263	-109 Reduced 2.07%	5,147 $368,000
Q1 2023 May 15, 2023	SELL	$63.15 - $71.6 $4,862 - $5,513	-77 Reduced 1.44%	5,256 $364,000
Q4 2022 Feb 13, 2023	SELL	$54.21 - $70.44 $13,986 - $18,173	-258 Reduced 4.61%	5,333 $361,000
Q3 2022 Nov 14, 2022	BUY	$53.02 - $135.75 $25,290 - $64,752	477 Added 9.33%	5,591 $307,000
Q2 2022 Aug 16, 2022	SELL	$59.26 - $71.14 $112,001 - $134,454	-1,890 Reduced 26.98%	5,114 $338,000
Q1 2022 Feb 08, 2024	SELL	$55.72 - $67.12 $75,946 - $91,484	-1,363 Reduced 19.44%	5,647 $374,000
Q4 2021 Feb 17, 2022	SELL	$54.02 - $63.83 $8,859 - $10,468	-164 Reduced 2.29%	7,004 $408,000
Q3 2021 Dec 03, 2021	BUY	$55.56 - $60.79 $9,778 - $10,699	176 Added 2.52%	7,168 $431,000
Q2 2021 Aug 17, 2021	BUY	$48.42 - $60.18 $2,033 - $2,527	42 Added 0.6%	6,992 $422,000
Q1 2021 May 24, 2021	SELL	$47.16 - $54.44 $34,521 - $39,850	-732 Reduced 9.53%	6,950 $344,000
Q4 2020 Feb 16, 2021	BUY	$48.52 - $58.02 $80,979 - $96,835	1,669 Added 27.76%	7,682 $384,000
Q3 2020 Nov 19, 2020	BUY	$53.07 - $61.1 $68,725 - $79,124	1,295 Added 27.45%	6,013 $329,000
Q2 2020 Aug 14, 2020	BUY	$43.1 - $55.31 $203,345 - $260,952	4,718 New	4,718 $250,000
Q1 2020 May 11, 2020	SELL	$37.79 - $51.33 $159,851 - $217,125	-4,230 Closed	0 $0
Q4 2019 Jan 31, 2020	BUY	$42.46 - $50.46 $179,605 - $213,445	4,230 New	4,230 $211,000

Others Institutions Holding AZN

# of Institutions

1,360

Shares Held

476M

Call Options Held

5.39M

Put Options Held

3.75M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $206B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kingsview Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kingsview Wealth Management, LLC with notifications on news.

Account

Kingsview Wealth Management, LLC Astrazeneca PLC Transaction History